Cyabra, Inc. reports first-quarter 2026 results following its March 27 business combination and Nasdaq listing. Revenue rose to $1.4 million from $1.3 million, but net loss widened to $10.8 million from $3.3 million, driven by higher R&D, general and administrative costs, and $5.2 million in stock-based compensation plus $3.4 million of one-time business combination expenses.
Adjusted EBITDA was a loss of $3.2 million. Cash and cash equivalents were $3.1 million as of March 31, 2026, after receiving $8,000 from PIPE financing and merger proceeds. Management states there is substantial doubt about Cyabra’s ability to continue as a going concern without additional financing. Annualized recurring revenue reached $7.0 million, up from $5.9 million a year earlier, reflecting growth in longer-term contracts.
Cyabra also discloses a Nasdaq notice that its market value of listed securities was below $50 million for 30 consecutive business days, triggering a 180-day compliance period ending on November 9, 2026 to regain listing compliance.
Cyabra, Inc. reported a Schedule 13G/A amendment showing Lowenstein Sandler LLP held 266,000 shares of Common Stock as of May 5, 2026. The amendment states this position represents approximately 1.9% of the outstanding common shares, based on 13,814,167 shares outstanding as of March 27, 2026.
CYAB, INC. received an initial insider ownership filing showing a significant stake in its common stock. The Form 3 reports that Trailblazer Sponsor Group, LLC beneficially owns 2,158,949 shares of CYAB common stock, par value $0.0001 per share.
Trailblazer Sponsor Group, LLC and Joseph D. Hammer are each reported as ten percent owners. The footnote explains that the shares are held directly by the Sponsor, while Mr. Hammer, as manager of the Sponsor, has voting and dispositive power over these shares but disclaims beneficial ownership except for his pecuniary interest. The filing reflects existing holdings rather than a new share purchase or sale.
Cyabra, Inc. reports a Schedule 13G disclosing a 15.6% beneficial ownership position. As of March 27, 2026, Trailblazer Sponsor Group, LLC is the record holder of 2,158,949 shares, based on 13,814,167 shares outstanding as of March 27, 2026. The filing states Joseph Hammer is manager of the Sponsor, has voting and dispositive power over the Sponsor's shares, and disclaims beneficial ownership except to the extent of any pecuniary interest.
Cyabra, Inc. director and Chief Product Officer Yossef Daar filed a Schedule 13D reporting a 5.1% beneficial ownership stake in the company’s common stock. He holds 710,549 shares, including stock received in Cyabra’s business combination and fully vested restricted stock units, and is subject to a nine‑month lock-up on sales.
Cyabra, Inc. Chief Executive Officer Dan Brahmy filed a Schedule 13D disclosing beneficial ownership of 711,548 shares of common stock, representing 5.1% of Cyabra’s outstanding shares as of March 27, 2026. This stake arose from Cyabra’s business combination with Trailblazer Merger Corporation I and related equity awards.
The holdings include 535,402 shares held in trust, 134,000 fully vested restricted stock units granted for his service as CEO and director, and options for 42,146 shares exercisable at $0.0009 per share, expiring on November 13, 2033. Under a Lock-Up Agreement, Brahmy agreed not to sell or hedge these securities for nine months from March 27, 2026, limiting his ability to dispose of shares in the near term while he evaluates his investment on an ongoing basis.
Cyabra, Inc.'s Chief Technology Officer, Ido Shraga, reports beneficial ownership of 710,549 shares of common stock, or 5.1% of Cyabra, Inc. (CYAB). His stake reflects shares received in a business combination between Trailblazer entities and Cyabra Strategy Ltd., plus a fully vested equity grant.
Most of his position comes from 577,549 shares of common stock issued in exchange for 160,000 Cyabra ordinary shares at the merger’s effective time. He also holds 133,000 shares underlying restricted stock units granted for his CTO service. A lock-up agreement restricts sales or hedging of these securities for nine months from March 27, 2026.
Cyabra, Inc. ownership disclosure: Lowenstein Sandler LLP reported beneficial ownership of 1,000,000 shares of Cyabra common stock as of March 27, 2026. The filing states this equals approximately 7.2% of the 13,814,167 shares outstanding reported to the reporting person on that date.
The reporting person reports sole voting and sole dispositive power over the 1,000,000 shares. The Schedule 13G is signed by David Wissert as General Counsel on April 1, 2026.
CYABRA, INC. Chief Product Officer Yossef Daar indirectly acquired common stock in connection with the company’s business combination and a new equity award. At the effective time of the Business Combination, 160,000 ordinary shares of Cyabra held for him were converted into 577,549 shares of the issuer’s common stock, held by IBI Trust Management in trust.
On March 27, 2026, he was also granted 133,000 restricted stock units under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, fully vested upon grant and effective 30 days after the 2026 Israeli Sub-Plan is filed with the Israel Tax Authority. Following these acquisitions, his indirect holdings reported in this filing total 710,549 shares.
CYABRA, INC. Chief Revenue Officer Emmanuel Heymann received two stock option awards tied to the company’s recent business combination. He was granted options over 25,264 shares of common stock at a $1.00 exercise price and options over 28,883 shares at a $7.53 exercise price, both expiring on February 19, 2033.
These options replace prior Cyabra Strategy Ltd. options under the Cyabra, Inc. 2026 Omnibus Incentive Plan. The January 2023 Replacement Option and January 2025 Replacement Option each vest over three years and ten months, with 25% vesting 10 months after their respective January 1 vesting commencement dates and the remainder vesting in equal monthly installments.